{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:11:21Z","timestamp":1767139881347,"version":"build-2238731810"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"345 Talent Project of Shengjing Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00415-021-10487-9","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T15:02:21Z","timestamp":1614956541000},"page":"1353-1367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness comparisons of antiviral treatments for Bell palsy: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3166-8404","authenticated-orcid":false,"given":"Jiajie","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-7137","authenticated-orcid":false,"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-2461","authenticated-orcid":false,"given":"Zhiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"issue":"7","key":"10487_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0269215510395634","volume":"25","author":"LM Pereira","year":"2011","unstructured":"Pereira LM, Obara K, Dias JM, Menacho MO, Lavado EL, Cardoso JR (2011) Facial exercise therapy for facial palsy: systematic review and meta-analysis. Clin Rehabil 25(7):649\u2013658. https:\/\/doi.org\/10.1177\/0269215510395634","journal-title":"Clin Rehabil"},{"key":"10487_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/000164802760370736","volume":"549","author":"E Peitersen","year":"2002","unstructured":"Peitersen E (2002) Bell\u2019s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549:4\u201330","journal-title":"Acta Otolaryngol Suppl"},{"issue":"13","key":"10487_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJMcp041120","volume":"351","author":"DH Gilden","year":"2004","unstructured":"Gilden DH (2004) Clinical practice. Bell\u2019s Palsy N Engl J Med 351(13):1323\u20131331. https:\/\/doi.org\/10.1056\/NEJMcp041120","journal-title":"Bell's Palsy N Engl J Med"},{"issue":"5","key":"10487_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/lary.1978.88.5.787","volume":"88","author":"KK Adour","year":"1978","unstructured":"Adour KK, Byl FM, Hilsinger RL Jr, Kahn ZM, Sheldon MI (1978) The true nature of Bell\u2019s palsy: analysis of 1000 consecutive patients. Laryngoscope 88(5):787\u2013801. https:\/\/doi.org\/10.1002\/lary.1978.88.5.787","journal-title":"Laryngoscope"},{"issue":"6","key":"10487_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/MAO.0b013e3181ab31c8","volume":"30","author":"T Berg","year":"2009","unstructured":"Berg T, Axelsson S, Engstr\u00f6m M, Stjernquist-Desatnik A, Pitk\u00e4ranta A, Kanerva M, Jonsson L (2009) The course of pain in Bell\u2019s palsy: treatment with prednisolone and valacyclovir. Otol Neurotol 30(6):842\u2013846. https:\/\/doi.org\/10.1097\/MAO.0b013e3181ab31c8","journal-title":"Otol Neurotol"},{"key":"10487_CR6","doi-asserted-by":"publisher","first-page":"006283","DOI":"10.1002\/14651858.CD006283.pub3","volume":"12","author":"LJ Teixeira","year":"2011","unstructured":"Teixeira LJ, Valbuza JS, Prado GF (2011) Physical therapy for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 12:006283. https:\/\/doi.org\/10.1002\/14651858.CD006283.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"10487_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/00016489209136829","volume":"492","author":"E Peitersen","year":"1992","unstructured":"Peitersen E (1992) Natural history of Bell\u2019s palsy. Acta Otolaryngol Suppl 492:122\u2013124. https:\/\/doi.org\/10.3109\/00016489209136829","journal-title":"Acta Otolaryngol Suppl"},{"issue":"11","key":"10487_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/s1474-4422(08)70221-7","volume":"7","author":"M Engstr\u00f6m","year":"2008","unstructured":"Engstr\u00f6m M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitk\u00e4ranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L (2008) Prednisolone and valaciclovir in Bell\u2019s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 7(11):993\u20131000. https:\/\/doi.org\/10.1016\/s1474-4422(08)70221-7","journal-title":"Lancet Neurol"},{"key":"10487_CR9","doi-asserted-by":"publisher","first-page":"cd001869","DOI":"10.1002\/14651858.CD001869.pub4","volume":"4","author":"P Lockhart","year":"2009","unstructured":"Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F (2009) Antiviral treatment for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 4:cd001869. https:\/\/doi.org\/10.1002\/14651858.CD001869.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"10487_CR10","doi-asserted-by":"publisher","first-page":"cd001942","DOI":"10.1002\/14651858.CD001942.pub4","volume":"3","author":"RA Salinas","year":"2010","unstructured":"Salinas RA, Alvarez G, Daly F, Ferreira J (2010) Corticosteroids for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 3:cd001942. https:\/\/doi.org\/10.1002\/14651858.CD001942.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10487_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MAO.0b013e3181cabd90","volume":"31","author":"TE Linder","year":"2010","unstructured":"Linder TE, Abdelkafy W, Cavero-Vanek S (2010) The management of peripheral facial nerve palsy: \u201cparesis\u201d versus \u201cparalysis\u201d and sources of ambiguity in study designs. Otol Neurotol 31(2):319\u2013327. https:\/\/doi.org\/10.1097\/MAO.0b013e3181cabd90","journal-title":"Otol Neurotol"},{"issue":"41","key":"10487_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3238\/arztebl.2019.0692","volume":"116","author":"JG Heckmann","year":"2019","unstructured":"Heckmann JG, Urban PP, Pitz S, Guntinas-Lichius O, G\u00e1gyor I (2019) The Diagnosis and treatment of idiopathic facial paresis (Bell\u2019s Palsy). Dtsch Arztebl Int 116(41):692\u2013702. https:\/\/doi.org\/10.3238\/arztebl.2019.0692","journal-title":"Dtsch Arztebl Int"},{"issue":"3 Suppl","key":"10487_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599813505967","volume":"149","author":"RF Baugh","year":"2013","unstructured":"Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, Deckard NA, Dawson C, Driscoll C, Gillespie MB, Gurgel RK, Halperin J, Khalid AN, Kumar KA, Micco A, Munsell D, Rosenbaum S, Vaughan W (2013) Clinical practice guideline: Bell\u2019s palsy. Otolaryngol Head Neck Surg 149(3 Suppl):S1-27. https:\/\/doi.org\/10.1177\/0194599813505967","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10487_CR14","doi-asserted-by":"publisher","first-page":"Cd001869","DOI":"10.1002\/14651858.CD001869.pub8","volume":"11","author":"I Gagyor","year":"2015","unstructured":"Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F (2015) Antiviral treatment for Bell\u2019s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 11:Cd001869. https:\/\/doi.org\/10.1002\/14651858.CD001869.pub8","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10487_CR15","first-page":"559","volume":"21","author":"X Fu","year":"2018","unstructured":"Fu X, Tang L, Wang C, Li M, Wu H, Li J, Ma Q, Yang W (2018) A Network Meta-analysis to compare the efficacy of steroid and antiviral medications for facial paralysis from Bell\u00b4s Palsy. Pain Physician 21(6):559\u2013569","journal-title":"Pain Physician"},{"issue":"19","key":"10487_CR16","doi-asserted-by":"publisher","first-page":"e15566","DOI":"10.1097\/md.0000000000015566","volume":"98","author":"R Zhang","year":"2019","unstructured":"Zhang R, Wu T, Wang R, Wang D, Liu Q (2019) Compare the efficacy of acupuncture with drugs in the treatment of Bell\u2019s palsy: a systematic review and meta-analysis of RCTs. Medicine (Baltimore) 98(19):e15566. https:\/\/doi.org\/10.1097\/md.0000000000015566","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10487_CR17","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.23812\/20-339-a","volume":"34","author":"F Agostini","year":"2020","unstructured":"Agostini F, Mangone M, Santilli V, Paoloni M, Bernetti A, Saggini R, Paolucci T (2020) Idiopathic facial palsy: umbrella review of systematic reviews and meta-analyses. J Biol Regul Homeost Agents 34(4):1245\u20131255. https:\/\/doi.org\/10.23812\/20-339-a","journal-title":"J Biol Regul Homeost Agents"},{"issue":"30","key":"10487_CR18","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.3346\/jkms.2020.35.e245","volume":"35","author":"SJ Kim","year":"2020","unstructured":"Kim SJ, Lee HY (2020) Acute peripheral facial palsy: recent guidelines and a systematic review of the literature. J Korean Med Sci 35(30):e245. https:\/\/doi.org\/10.3346\/jkms.2020.35.e245","journal-title":"J Korean Med Sci"},{"key":"10487_CR19","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647. https:\/\/doi.org\/10.1136\/bmj.g7647","journal-title":"BMJ"},{"key":"10487_CR20","doi-asserted-by":"publisher","first-page":"Ed00042","DOI":"10.1002\/14651858.Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for systematic reviews of interventions. Cochrane Database Syst Rev 10:Ed00042. https:\/\/doi.org\/10.1002\/14651858.Ed000142","journal-title":"Cochrane Database Syst Rev"},{"key":"10487_CR21","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors) (2020) Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (Updated September 2020). Cochrane. www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"11","key":"10487_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catal\u00e1-L\u00f3pez F, G\u00f8tzsche PC, Dickersin K, Boutron I, Altman DG, Moher D (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784. https:\/\/doi.org\/10.7326\/m14-2385","journal-title":"Ann Intern Med"},{"issue":"4","key":"10487_CR23","first-page":"155","volume":"114","author":"B Stegenga","year":"2007","unstructured":"Stegenga B, Dijkstra PU (2007) Principles of evidence-based medicine applied to dentistry. Ned Tijdschr Tandheelkd 114(4):155\u2013160","journal-title":"Ned Tijdschr Tandheelkd"},{"key":"10487_CR24","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"10487_CR25","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"2","key":"10487_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jrsm.1044","volume":"3","author":"JP Higgins","year":"2012","unstructured":"Higgins JP, Jackson D, Barrett JK, Lu G, Ades AE, White IR (2012) Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 3(2):98\u2013110. https:\/\/doi.org\/10.1002\/jrsm.1044","journal-title":"Res Synth Methods"},{"issue":"20","key":"10487_CR27","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23(20):3105\u20133124. https:\/\/doi.org\/10.1002\/sim.1875","journal-title":"Stat Med"},{"issue":"3","key":"10487_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0962280207080643","volume":"17","author":"G Salanti","year":"2008","unstructured":"Salanti G, Higgins JP, Ades AE, Ioannidis JP (2008) Evaluation of networks of randomized trials. Stat Methods Med Res 17(3):279\u2013301. https:\/\/doi.org\/10.1177\/0962280207080643","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"10487_CR29","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G (2013) Graphical tools for network meta-analysis in STATA. PLoS ONE 8(10):e76654. https:\/\/doi.org\/10.1371\/journal.pone.0076654","journal-title":"PLoS ONE"},{"issue":"2","key":"10487_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64(2):163\u2013171. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.016","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10487_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/eb-2015-102088","volume":"18","author":"D Mavridis","year":"2015","unstructured":"Mavridis D, Giannatsi M, Cipriani A, Salanti G (2015) A primer on network meta-analysis with emphasis on mental health. Evid Based Ment Health 18(2):40\u201346. https:\/\/doi.org\/10.1136\/eb-2015-102088","journal-title":"Evid Based Ment Health"},{"issue":"7","key":"10487_CR32","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","volume":"9","author":"G Salanti","year":"2014","unstructured":"Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP (2014) Evaluating the quality of evidence from a network meta-analysis. PLoS ONE 9(7):e99682. https:\/\/doi.org\/10.1371\/journal.pone.0099682","journal-title":"PLoS ONE"},{"issue":"4","key":"10487_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1517\/14740338.2010.485189","volume":"9","author":"S Mubareka","year":"2010","unstructured":"Mubareka S, Leung V, Aoki FY, Vinh DC (2010) Famciclovir: a focus on efficacy and safety. Expert Opin Drug Saf 9(4):643\u2013658. https:\/\/doi.org\/10.1517\/14740338.2010.485189","journal-title":"Expert Opin Drug Saf"},{"key":"10487_CR34","volume-title":"Famciclovir","author":"JR Semaan","year":"2020","unstructured":"Semaan JR, Parmar M (2020) Famciclovir. StatPearls Publishing, StatPearls"},{"key":"10487_CR35","unstructured":"Copyright \u00a9 2020, StatPearls Publishing LLC., Treasure Island (FL),"},{"issue":"12","key":"10487_CR36","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1128\/aac.36.12.2747","volume":"36","author":"DL Earnshaw","year":"1992","unstructured":"Earnshaw DL, Bacon TH, Darlison SJ, Edmonds K, Perkins RM, Vere Hodge RA (1992) Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother 36(12):2747\u20132757. https:\/\/doi.org\/10.1128\/aac.36.12.2747","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10487_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/aac.33.2.223","volume":"33","author":"RA Hodge","year":"1989","unstructured":"Hodge RA, Perkins RM (1989) Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob Agents Chemother 33(2):223\u2013229. https:\/\/doi.org\/10.1128\/aac.33.2.223","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10487_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2165\/00003495-199550020-00011","volume":"50","author":"CM Perry","year":"1995","unstructured":"Perry CM, Wagstaff AJ (1995) Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections. Drugs 50(2):396\u2013415. https:\/\/doi.org\/10.2165\/00003495-199550020-00011","journal-title":"Drugs"},{"issue":"2","key":"10487_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/infdis\/173.2.291","volume":"173","author":"AM Thackray","year":"1996","unstructured":"Thackray AM, Field HJ (1996) Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency. J Infect Dis 173(2):291\u2013299. https:\/\/doi.org\/10.1093\/infdis\/173.2.291","journal-title":"J Infect Dis"},{"issue":"7","key":"10487_CR40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1128\/aac.42.7.1555","volume":"42","author":"AM Thackray","year":"1998","unstructured":"Thackray AM, Field HJ (1998) Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. Antimicrob Agents Chemother 42(7):1555\u20131562. https:\/\/doi.org\/10.1128\/aac.42.7.1555","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10487_CR41","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1128\/aac.39.5.1114","volume":"39","author":"HJ Field","year":"1995","unstructured":"Field HJ, Tewari D, Sutton D, Thackray AM (1995) Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model. Antimicrob Agents Chemother 39(5):1114\u20131119. https:\/\/doi.org\/10.1128\/aac.39.5.1114","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10487_CR42","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1128\/aac.45.7.2044-2053.2001","volume":"45","author":"JM Loutsch","year":"2001","unstructured":"Loutsch JM, Sainz B Jr, Marquart ME, Zheng X, Kesavan P, Higaki S, Hill JM, Tal-Singer R (2001) Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits. Antimicrob Agents Chemother 45(7):2044\u20132053. https:\/\/doi.org\/10.1128\/aac.45.7.2044-2053.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10487_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2018.04.4324","volume":"72","author":"H Pott Junior","year":"2018","unstructured":"Pott Junior H, de Oliveira MFB, Gambero S, Amazonas RB (2018) Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults. Int J Infect Dis 72:11\u201315. https:\/\/doi.org\/10.1016\/j.ijid.2018.04.4324","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10487_CR44","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1097\/mjt.0000000000000436","volume":"25","author":"M Yaldiz","year":"2018","unstructured":"Yaldiz M, Solak B, Kara RO, Cosansu N, Erdem MT (2018) Comparison of Famciclovir, Valaciclovir, and Brivudine Treatments in Adult Immunocompetent Patients With Herpes Zoster. Am J Ther 25(6):e626\u2013e634. https:\/\/doi.org\/10.1097\/mjt.0000000000000436","journal-title":"Am J Ther"},{"issue":"11","key":"10487_CR45","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00415-008-0008-6","volume":"255","author":"M Minnerop","year":"2008","unstructured":"Minnerop M, Herbst M, Fimmers R, Kaabar P, Matz B, Klockgether T, W\u00fcllner U (2008) Bell\u2019s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J Neurol 255(11):1726\u20131730. https:\/\/doi.org\/10.1007\/s00415-008-0008-6","journal-title":"J Neurol"},{"issue":"1","key":"10487_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/01.mlg.0000248737.65607.9e","volume":"117","author":"K Kawaguchi","year":"2007","unstructured":"Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, Matsuzaki Y, Nishimura H, Ishikawa H, Fukao A et al (2007) Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell\u2019s palsy. Laryngoscope 117(1):147\u2013156. https:\/\/doi.org\/10.1097\/01.mlg.0000248737.65607.9e","journal-title":"Laryngoscope"},{"issue":"5","key":"10487_CR47","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/joim.12288","volume":"277","author":"HM Kang","year":"2015","unstructured":"Kang HM, Jung SY, Byun JY, Park MS, Yeo SG (2015) Steroid plus antiviral treatment for Bell\u2019s palsy. J Intern Med 277(5):532\u2013539","journal-title":"J Intern Med"}],"updated-by":[{"DOI":"10.1007\/s00415-022-10976-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10487-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10487-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T02:16:00Z","timestamp":1645150560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10487-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10487"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10487-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00415-022-10976-5","URL":"https:\/\/doi.org\/10.1007\/s00415-022-10976-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}